N-Carbethoxy-4-piperidone

CAS No. 29976-53-2

N-Carbethoxy-4-piperidone ( —— )

Catalog No. M13925 CAS No. 29976-53-2

Aminopyrimidine derivatives, processes for their preparation, compositions containing them and their use as pharmaceuticals.

Purity : >98%(HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1G 26 In Stock

Biological Information

  • Product Name
    N-Carbethoxy-4-piperidone
  • Note
    Research use only, not for human use.
  • Brief Description
    Aminopyrimidine derivatives, processes for their preparation, compositions containing them and their use as pharmaceuticals.
  • Description
    Aminopyrimidine derivatives, processes for their preparation, compositions containing them and their use as pharmaceuticals.
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    29976-53-2
  • Formula Weight
    171.19
  • Molecular Formula
    C8H13NO3
  • Purity
    >98%(HPLC)
  • Solubility
    Limited solubility
  • SMILES
    CCOC(=O)N1CCC(=O)CC1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Eric Gundersen et al.Bioorganic & Medicinal Chemistry Letters, 15(7), 1891-1894 (2005)
molnova catalog
related products
  • Syk Inhibitor II hyd...

    The impact of spleen tyrosine kinase (Syk) signaling might be prominent in lupus because (i) Syk is a shared downstream signaling molecule among circulating immune complex, LPS, and (1→3)-β-D-glucan (BG), and (ii) all of these factors are detectable in the serum of Fc gamma receptor IIb-deficient (FcgRIIb-/-) mice with sepsis. Syk inhibition downregulated several inflammatory pathways in FcgRIIb-/- macrophages activated with BG + LPS suggesting the potential anti-inflammatory impact of Syk inhibitors in lupus.

  • DL-Homocystine

    Homocystine is the double-bonded form of homocysteine but it occurs only transiently before being converted to the harmless cystathionine via a vitamin B6-dependent enzyme. Homocystine and homocysteine-cysteine mixed disulfide account for >98% of total homocysteine in plasma from healthy individuals.

  • L-BUTHIONINE-(SR)-SU...

    L-Buthionine-(SR)-sulfoximine is a cell-permeable and irreversible inhibitor of γ-glutamylcysteine synthetase (Ki <100 μM) that induces oxidative stress in cells by depleting GSH.